Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTMI vs GSK✓SelectedUSD · GSKTTMI vs GSK performance historyLatest closeAs of-2.03%11/19
Stock and ETF performance explorer

TTMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+417.1%
GSK return
+97.7%
Excess return
+319.4%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.5%-1.8%
7D-10.9%-4.7%-6.1%-10.2%
30D-28.8%-4.7%-24.1%-28.4%
3M-41.6%-8.8%-32.8%-40.9%
6M-57.9%-4.6%-53.2%-58.1%
YTD-1.4%+1.0%-2.4%-3.8%
1Y+5.8%+6.9%-1.1%+1.6%
3Y+370.3%+52.5%+317.7%+291.9%
5Y+377.2%+40.3%+336.9%+299.3%
All+417.1%+97.7%+319.4%+282.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling